Viral infection of the CNS can result in encephalitis and acute seizures, increasing the risk for later-life epilepsy. We have previously characterized a novel animal model of temporal lobe epilepsy that recapitulates key sequela in the development of epilepsy following viral infection. C57BL/6 J mice inoculated with the Daniel's strain of Theiler's Murine Encephalomyelitis Virus (TMEV; 3 × 10 5 PFU, i.c.) display acute limbic seizures that secondarily generalize. A majority of acutely seized animals develop spontaneous seizures weeks to months later. As part of our investigation, we sought to assess behavioral comorbidity following TMEV inoculation. Anxiety, depression, cognitive impairment, and certain psychoses are diagnosed in persons with epilepsy at rates far more frequent than in the general population. We used a battery of behavioral tests to assess anxiety, depression, cognitive impairment, and general health in acutely seized animals inoculated with TMEV and compared behavioral outcomes against age-matched controls receiving a sham injection. We determined that TMEV-seized animals are less likely to move through the exposed center of an open field and are less likely to enter into the lighted half of a light/dark box; both behaviors may be indicative of anxiety-like behavior. TMEV-seized animals also display early and persistent reductions in novel object exploration during novel object place tasks and do not improve in their ability to find a hidden escape platform in Morris water maze testing, indicative of impairment in episodic and spatial memory, respectively. Cresyl violet staining at 35 and 250 days after injection reveals bilateral reductions in hippocampal area, with extensive sclerosis of CA1 evident bilaterally along the rostral-caudal axis. Early and persistent behavioral changes in the TMEV model provide surrogate markers for assessing disease progression as well as endpoints in screening for the efficacy of novel compounds to manage both seizure burden and comorbid conditions.
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Introduction
While most epilepsy etiology is idiopathic in nature, a growing literature describes the prevalence of acquired epilepsy following viral infection. Viral infections of the CNS can result in encephalitis, which has the ability to provoke early acute seizures, increasing the risk for unprovoked, later-life seizures 22-fold (Michael and Solomon, 2012; Misra et al., 2008a) . In the United States, encephalitis leads to as many new cases of acquired epilepsy as head trauma (Misra et al., 2008a) .
Our group has previously characterized the first infection-based animal model of epilepsy, closely recapitulating temporal lobe epilepsy (TLE). Intracortical injection of Theiler's Murine Encephalomyelitis Virus (TMEV) into C57BL/6 J mice leads to acute encephalitic seizures from 3 to 10 days post injection (DPI) (Libbey et al., 2008; Stewart et al., 2010) . TMEV antigens are present bilaterally in limbic and temporal areas during acute infection, including hippocampus (notably CA1 and CA2), periventricular thalamic nuclei, septal nuclei, and piriform, parietal, and entorhinal cortices (Stewart et al., 2009 ), but are virtually undetectable by 14 DPI (Kirkman et al., 2010; Libbey et al., 2011) . During the acute, active infection period, neuronal death is observed preferentially among CA1 and CA2 neurons of the hippocampus (Stewart et al., 2009) . After acute infection and viral clearance, a latent period of weeks to months precedes infrequent spontaneous seizures (approximately 2 seizures/animal/week) in a majority of animals seized during acute infection (Stewart et al., 2010) . The TMEV model reflects periods of human epilepsy development following viral infection, and as such, this model may serve as a useful platform in the development and screening of disease modifying therapeutics administered during periods of acute infection.
TLE is the most common form of focal epilepsy and often the most refractory to currently available anti-seizure drugs; like many forms of
